Pharmaceutical Executive, March 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive March 2021 issue in an interactive PDF format.
Articles in this issue
The Amazon Effect: A Data-Fueled Customer Experience
Why ESG Performance Metrics Matter
Pharma and Biotech’s 2020 Full-Year View
Persevering for Patients
Biopharma’s Reputation Gets a Well-Earned Shot in the Arm
IP and Capital
IP and COVID-19
Pharma Steps Up for Public Health Inequities
FDA Relays Recent Achievements, Maps Plans for Progress
IP and Collaboration
Pharmaceutical Executive, March 2021 Issue (PDF)
Pharm Exec at 40 (1986-1989)
How Cross-Functional Interactions Can Boost Collaboration
Attracting the Right Data Science Talent
COVID-19 Catalyzing Changes in European Medicines Regulation
Recent Videos
Related Content
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Podcast
Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Novo Nordisk, The United Laboratories Ink Exclusive License Agreement for Triple Receptor Agonist
March 25th 2025Article
Under terms of the license agreement, Novo Nordisk will acquire the rights to develop and commercialize UBT251 outside of China for obesity and type 2 diabetes for an upfront payment of $200 million.
